Amneal’s generic Namenda XR introducedThe product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data. FDA approves Lupin’s generic Tamiflu for oral suspensionThe product had U.S. sales of roughly $358 million for the 12 months ended October 2017, according to IQVIA data. Impax launches authorized Solodyn generic Impax’s authorized Solodyn generic will be available in 65- and 115-mg dosage strength. Teva launches generic Solodyn Teva’s generic Solodyn will be available in 65- and 115-mg dosage strengths. Camber launches generic Celexa oral solution Camber’s generic Celeca oral solution will be available in a 240-ml bottle of 10 mg/5 ml dosage strength. Camber’s generic Viread launches Camber’s generic Viread will be available in 30-count tablets of 300-mg dosage strength tablets. Sandoz launches new dosage strength of its Copaxone generic Glatopa is indicated to treat relapsing forms of multiple sclerosis, and Sandoz developed Glatopa through a collaboration agreement between itself and Momenta Pharmaceuticals. FDA tentatively approves Lupin’s generic Locoid lotion Lupin’s generic Locoid Lotion is indicated for the topical treatment of mild to moderate atopic dermatitis. Lupin intros Tamiflu generic The product had U.S. sales of roughly $518 million for the 12 months ended December 2017, according to IQVIA data. Teva launches generic of Syprine The drug was included on the Food and Drug Administration’s list of off-patent, off-exclusivity branded drugs that didn’t have generics. First Previous 213 214 215 216 217 Next Last